Clinical trials are facing a persistent challenge: keeping patients enrolled and engaged throughout the duration of a study. On Oct. 28, 2026, clinical trial technology company Suvoda announced a series of major enhancements to Greenphire Travel, its specialized software and services platform designed to remove the logistical hurdles that prevent patients from participating in clinical research.

Travel logistics represent one of the most significant barriers to clinical trial enrollment and retention. According to a study by the Center for Information and Study on Clinical Research Participation (CISCRP), among participants who found their study disruptive, 49% cited travel to the study clinic as a primary cause. By expanding the capabilities of Greenphire Travel, Suvoda aims to directly address this pain point, offering sponsors, contract research organizations (CROs), and patients a more flexible and integrated travel experience.

Addressing the Logistical Barriers of Clinical Research

For many patients, participating in a clinical trial is an added layer of complexity on top of managing a serious illness. The physical and emotional toll of traveling to and from clinic visits can lead to high drop-out rates, which in turn delays drug development timelines and increases trial costs.

Elizabeth Smith, Director of Product Management, Patient Experience at Suvoda, emphasized the importance of simplifying this journey. According to Smith, participants in clinical trials are often managing serious illness on top of the logistical demands of getting to visits. She noted that Greenphire Travel is designed to remove the coordination burden from sites and their patients so they can focus on their health and wellbeing.

By streamlining the travel process, the updated platform seeks to make participation more accessible, particularly for individuals who may otherwise struggle with the financial or physical demands of regular clinic visits.

Integrated Rideshare Access and Patient Autonomy

A key feature of the latest Greenphire Travel release is the expansion of global rideshare and car services. Depending on the region, participants and clinical sites now have direct access to major transportation providers, including Lyft, Uber Health, and Bolt.

This integration is managed directly through the Suvoda App, creating a single digital touchpoint for the entire trial journey. Through the app, participants can:

  • View detailed travel itineraries, including flights and hotel bookings
  • Book eligible rideshare services directly
  • Monitor real-time rideshare and trip status
  • Manage study appointments and complete questionnaires
  • Track and manage study-related payments

This consolidated approach reduces the administrative burden on clinical site staff, who previously had to manually coordinate routine travel requests and handle status inquiries. With patients gaining direct control over their travel arrangements, sites can redirect their focus toward clinical care.

Flexible Support Models: Site-Led vs. Concierge

Recognizing that clinical trials vary widely in scope and complexity, Suvoda has structured Greenphire Travel to offer two distinct delivery models. This flexibility allows sponsors to tailor travel support to the specific needs of each study or site:

  • Site-Led Model: This option allows study teams to easily initiate straightforward, routine travel requests directly through the software, making it ideal for less complex trials.
  • Concierge Model: Designed for highly complex studies or patients with intensive needs, this model provides high-touch, personalized coordination. Concierge coordinators are stationed across 40+ countries and are available 24/7 to support participants for the duration of a trial.

This dual-model approach is particularly critical for specialized research. Will Wing noted that clinical trials vary enormously in complexity, and the travel support behind them should too. He pointed out that sponsors can choose the level of service that fits each study or site rather than applying a single model across their entire portfolio, which can make a significant difference for patients in oncology or rare disease trials.

Global Footprint and Financial Accessibility

One of the primary barriers to trial participation is the upfront cost of travel. To eliminate this financial stress, Greenphire Travel operates on a $0 out-of-pocket model for patients, caregivers, and sites. Eligible travel expenses are funded upfront by the sponsor and managed directly through Suvoda, eliminating reimbursement delays and financial anxiety for participants.

To date, Greenphire Travel has established a substantial global footprint, supporting more than 8,400 sites across 2,000+ trials in over 50 countries. With localized, native-language support provided by coordinators in 40+ countries, the platform is positioned to support diverse patient populations worldwide, helping clinical trials maintain high retention rates and achieve more reliable outcomes.